Literature DB >> 12794085

The role of collagen structure in mitogen stimulation of ERK, cyclin D1 expression, and G1-S progression in rat hepatocytes.

John T Fassett1, Diane Tobolt, Christopher J Nelsen, Jeffrey H Albrecht, Linda K Hansen.   

Abstract

Adhesion to type 1 collagen can elicit different cellular responses dependent upon whether the collagen is in a fibrillar form (gel) or monomeric form (film). Hepatocytes adherent to collagen film spread extensively, express cyclin D1, and increase DNA synthesis in response to epidermal growth factor, whereas hepatocytes adherent to collagen gel have increased differentiated function, but lower DNA synthesis. The signaling mechanisms by which different forms of type I collagen modulate cell cycle progression are unknown. When ERK MAP kinase activation was analyzed in hepatocytes attached to collagen film, two peaks of ERK activity were demonstrated. Only the second peak, which correlated with an increase of cyclin D1, was required for G1-S progression. Notably, this second peak of ERK activity was absent in cells adherent to collagen gel, but not required in the presence of exogenous cyclin D1. Expression of activated mutants of the Ras/Raf/MEK signaling pathway in cells adherent to collagen gel restored ERK phosphorylation and DNA synthesis, but differentially affected cell shape. Although Ras, Raf, and MEK all increased expression of cyclin D1 on collagen film, only Ras and Raf significantly up-regulated cyclin D1 levels on collagen gel. These results demonstrate that adhesion to polymerized collagen induces growth arrest by inhibiting the Ras/ERK-signaling pathway to cyclin D1 required in late G1.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12794085     DOI: 10.1074/jbc.M300899200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  11 in total

1.  Type I collagen structure regulates cell morphology and EGF signaling in primary rat hepatocytes through cAMP-dependent protein kinase A.

Authors:  John Fassett; Diane Tobolt; Linda K Hansen
Journal:  Mol Biol Cell       Date:  2005-10-26       Impact factor: 4.138

2.  ERK activity and G1 phase progression: identifying dispensable versus essential activities and primary versus secondary targets.

Authors:  Jessie Villanueva; Yuval Yung; Janice L Walker; Richard K Assoian
Journal:  Mol Biol Cell       Date:  2007-02-21       Impact factor: 4.138

3.  Differential effects of interferon alpha-2b and beta on the signaling pathways in human liver cancer cells.

Authors:  Kazuya Matsumoto; Jun-ichi Okano; Yoshikazu Murawaki
Journal:  J Gastroenterol       Date:  2005-07       Impact factor: 7.527

4.  Induction of intrahepatic cholangiocellular carcinoma by liver-specific disruption of Smad4 and Pten in mice.

Authors:  Xiaoling Xu; Shogo Kobayashi; Wenhui Qiao; Cuiling Li; Cuiying Xiao; Svetlana Radaeva; Bangyan Stiles; Rui-Hong Wang; Nobuya Ohara; Tadashi Yoshino; Derek LeRoith; Michael S Torbenson; Gregory J Gores; Hong Wu; Bin Gao; Chu-Xia Deng
Journal:  J Clin Invest       Date:  2006-06-08       Impact factor: 14.808

5.  Bone marrow stem-cell therapy for genetic and chronic liver diseases.

Authors:  Veena Kochat; Prakash Baligar; Rakhi Maiwall; Asok Mukhopadhyay
Journal:  Hepatol Int       Date:  2014-01-03       Impact factor: 6.047

6.  Ovarian carcinoma spheroids disaggregate on type I collagen and invade live human mesothelial cell monolayers.

Authors:  Kathryn M Burleson; Linda K Hansen; Amy P N Skubitz
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

7.  The elements of human cyclin D1 promoter and regulation involved.

Authors:  Zhi-Yi Guo; Xiao-Hui Hao; Fei-Fei Tan; Xin Pei; Li-Mei Shang; Xue-Lian Jiang; Fang Yang
Journal:  Clin Epigenetics       Date:  2011-02-11       Impact factor: 6.551

8.  Impact of alginate composition: from bead mechanical properties to encapsulated HepG2/C3A cell activities for in vivo implantation.

Authors:  Stephanie H Capone; Murielle Dufresne; Mathias Rechel; Marie-José Fleury; Anne-Virginie Salsac; Patrick Paullier; Martine Daujat-Chavanieu; Cecile Legallais
Journal:  PLoS One       Date:  2013-04-25       Impact factor: 3.240

9.  The MAPK MEK1/2-ERK1/2 Pathway and Its Implication in Hepatocyte Cell Cycle Control.

Authors:  Jean-Philippe Guégan; Christophe Frémin; Georges Baffet
Journal:  Int J Hepatol       Date:  2012-10-24

10.  3-phosphoinositide-dependent protein kinase-1 (PDK1) promotes invasion and activation of matrix metalloproteinases.

Authors:  Zhihui Xie; Hongyan Yuan; Yuzhi Yin; Xiao Zeng; Renkui Bai; Robert I Glazer
Journal:  BMC Cancer       Date:  2006-03-21       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.